Skip to main content

Table 3 Availability of ERT for MPS diseases in different countries

From: The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centers

 

Not available

Available for all ages

Available only for pediatric patients

Available only for some patients

Total

MPS Type I

2 (14%)

10 (71%)

1 (7%)

1 (7%)

14

MPS Type II

0 (0%)

12 (86%)

1 (7%)

1 (7%)

14

MPS Type IVA

2 (12.5%)

10 (62.5%)

2 (12.5%)

2 (12.5%)

16

MPS Type VI

2 (17%)

9 (75%)

0 (0%)

1 (8%)

12

MPS Type VII

9 (75%)

2 (17)%

0 (0%)

1 (8%)

12

  1. In brackets the % of respondents